New Colombia Resources (NEWC) Accelerates Plans to Import CBD-based Epilepsy Drug to U.S Upon GW Pharma's Positive Results of their CBD-based Epilepsy Formulation

Medical Marijuana subsidiary, Sannabis, has been successfully treating hundreds of Pediatric Epilepsy patients in Colombia for years.

Mar 15, 2016, 08:00 ET from New Colombia Resources, Inc.

CALI, Colombia, March 15, 2016 /PRNewswire/ --

New Colombia Resources, Inc. (OTC PINK: NEWC), a U.S. company with a Colombian medical marijuana subsidiary, Sannabis, is pleased with the positive results announced yesterday from GW Pharmaceutical's Phase III clinical trials for a CBD based Epilepsy formulation. New Colombia Resources' Sannabis subsidiary has developed a CBD product that is being tested to be legally imported to the U.S. to help children with epilepsy. These imports will eventually compete with big Pharma at much more affordable pricing. For now, they will compete with overpriced non effective CBD products that are being offered in the U.S. to many desperate families.

"Most medical marijuana companies are touting what they're going to do, we're doing it now and have been for some time," stated John Campo, President of New Colombia Resources, "Our 'Punto Rojo' and other native landrace strains are the most sought after in the World providing the best medicine.  Although our prices will be escalating with the implementation of new products and more advanced processes, for now our pure Cannabis Sativa and Cannabis Indica extracts retail from US$ 22 to $ 37 for 5 ml. Our highly effective skin healing creams and hot creams containing 5 grams of organic naturally grown cannabis retail in Colombia for under US$ 10.  To put this into economic context, 5 grams of medical marijuana grown in an artificial environment can retail in a U.S dispensary for over $ 100, add to that the cost of manufacturing the creams with our other ingredients, you can see why there's interest from the U.S.," continued Mr. Campo.

Sannabis has an agreement with the Cultivando Esperanza Foundation which treats hundreds of kids with epilepsy in Colombia.  They are the main supplier of medicine to the foundation and work to successfully treat as many patients as possible so that no child is turned away due to lack of economic wherewithal. According to several documented studies, on average 10.3 out of 1000 people in Colombia have some form of epilepsy, meaning 500,000 cases.  It has been reported that Latin America has 5-8 million people with epilepsy.  Adult cancer patients have also shown remarkable improvements after just a few weeks of their three-month cancer treatment that includes cannabis essential oils and extracts.  Visit Sannabis' YouTube channel for testimonials and other videos,  Dozens more testimonials are being filmed, edited, and translated to be uploaded soon.

Sannabis has thousands of organically grown medical marijuana plants and over 10,000 more soon to be planted.  Ideal growing conditions for native strains allow Sannabis to be the highest quality, lowest cost producer of Cannabis products in the Western Hemisphere.  In addition to 5 grams of cannabis, their creams are beeswax based with natural oils and other native plant extracts.

A new GMP laboratory will be fully operational by the end of March, initially over 40 pounds of marijuana per day will be processed.  On March 31, representatives from Colombia's National Drug Council (CNE), operating under the Ministry of Justice, are scheduled to visit Sannabis 'lab and medical marijuana plantations.  Although Sannabis operates legally on an autonomous Indian reservation in the Cauca Department of Colombia, they aim to be one of the first licensees of the Presidential decree legalizing medical marijuana signed this past December by President Santos.

To purchase Sannabis products in Colombia visit  To see our plants, processes, and patients, follow Sannabis on Facebook

To follow the Cultivando Esperanza Foundation visit

About New Colombia Resources, Inc.  

In addition to medical marijuana, New Colombia Resources, Inc. is focused on the acquisition and development of high-quality metallurgical coal properties and other available resources in the Republic of Colombia. They own 100% of La Tabaquera metallurgical coal mine in Colombia with an estimated 15-17 million tonnes of reserves and millions of cubic meters of aggregate rock material.  They are setting up their work site to begin processing aggregates for the growing building sector in the first half of 2016.  New Colombia Resources also holds a significant position in Sannabis which legally produces medical marijuana products in Colombia.  For Company information visit

Forward Looking Statements  

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements might not occur. Factors that could cause or contribute to such differences include financing, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations. New Colombia Resources, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements

New Colombia Resources, Inc.
John Campo, President
+(1)-410-236-8200 USA
+(57)-318-657-0918 Colombia

SOURCE New Colombia Resources, Inc.